Harnessing the Power of Stem Cells to Treat Parkinson's Disease.
Thanks for visiting our team page. This September, our team will be joining everyday heroes from communities across Canada as part of Parkinson SuperWalk.
Driven by a vision to liberate patients from degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicines. Founded in 2016, BlueRock and its team of preeminent scientists are pioneering cell therapies that restore critical natural functions in the body, with an initial focus on severe brain and heart conditions. BlueRock’s culture is defined by the highest ethical standards and an urgency to bring transformative treatments to all who would benefit.
BlueRock’s allogeneic cell therapy approach is designed to address a number of important, difficult-to-treat conditions spanning neurodegeneration, cardiovascular disease and other areas of high patient need.
Since Covid-19 has made it impossible for us to walk together this year, we are taking the walk to our own homes and neighbourhoods. Parkinsons doesn't sleep, so we don't either. Your dollars, no matter how small, are just as important this year as ever. Thank you for supporting our team and as a result, those living with Parkinsons everywhere who hope for a cure.
Every dollar raised and every new team member means new hope. Thank you!
Click names to view pages